Search
for

    Sort by

    Research 721–750 of 1000+

    1. Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia JAMA Dermatology · 2020 · 5 citations
    2. Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review Skin appendage disorders · 2020 · 5 citations
    3. [Hormonal profile in men with premature androgenic alopecia]. PubMed · 2000 · 4 citations
    4. British Menopause Society Tools for Clinicians: Testosterone replacement in menopause. Post Reproductive Health · 2019 · 3 citations
    5. RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause Journal of obstetrics and gynaecology Canada · 2014 · 3 citations
    6. The Mossman–Pacey Paradox Journal of Internal Medicine · 2019 · 2 citations
    7. Effects of 5-alpha reductase inhibitors Current Opinion in Urology · 2018 · 2 citations
    8. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    9. Finasteride adverse effects and post-finasteride syndrome; implications for dentists Journal of Mind and Medical Sciences · 2016 · 2 citations
    10. Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia 2010 · 2 citations
    11. Precocious Puberty Pediatrics in review · 2000 · 2 citations
    12. Is there a relationship between alopecia and anthropometric indicators? Modern scientific view Reports of Vinnytsia National Medical University · 2023 · 1 citations
    13. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia Journal of Dermatological Treatment · 2022 · 1 citations
    14. 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study Journal of The American Academy of Dermatology · 2020 · 1 citations
    15. Finasteride Counseling for Male Androgenetic Alopecia Should Reflect Updated Findings on Prostate Cancer Risk Skin appendage disorders · 2020 · 1 citations
    16. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Actas Dermo-Sifiliográficas · 2016 · 1 citations
    17. A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia Hair therapy & transplantation · 2015 · 1 citations
    18. Heterozygous 21‐hydroxylasedeficiency as a cause of hyperandrogenism Journal der Deutschen Dermatologischen Gesellschaft · 2012 · 1 citations
    19. The Action of Hanson’s Thymus Extract on the Mouse Journal of Experimental Biology · 1936 · 1 citations
    20. DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS Asclepius International Journal of Scientific Health Science · 2026
    21. EP1446 - ECE_2942 - Finasteride for treatment of androgenic male alopecia since puberty: case report European Journal of Endocrinology · 2026
    22. Impact of 5-alpha Reductase Inhibitors on Male Reproductive Health: A Review of Finasteride and Dutasteride. PubMed · 2026
    23. Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment Brain Sciences · 2026
    24. Post-finasteride syndrome: survey of dermatologists from the Spanish Hair and Nail Disorders Group Actas Dermo-Sifiliográficas · 2026
    25. Use of finasteride and minoxidil for the treatment of androgenetic alopecia: a review Revista Colombiana de Ciencias Químico Farmacéuticas · 2026
    26. Uso de finasterida e minoxidil para o tratamento da alopecia androgenética: uma revisão Magazine Portal Bibliotech Digital (Universidad Nacional de Colombia) · 2026
    27. Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility Journal of Pharmacy & Bioresources · 2026
    28. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    29. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    30. COMPLICAÇÕES DOS TRATAMENTOS DA ALOPÉCIA ANDROGÉNICA: REVISÃO SISTEMÁTICA E META-ANÁLISE Revista fisio&terapia. · 2025